What makes a healthcare brand stick? In this episode, VCCP Health unpacks CHESS moves: Character, Humor, Emotion, Surprise and Sonic Branding, and how they help brands move beyond awareness to become truly memorable. We explore how building memory structures, not just messaging, drives trust, behavior change and long-term brand impact.

Check us out at: mmm-online.com

Follow us:

YouTube: @MMM-online

TikTok: @MMMnews

Instagram: @MMMnewsonline

Twitter/X: @MMMnews

LinkedIn: MM+M

To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

Music: “Deep Reflection” by DP and Triple Scoop Music.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Over the past week, everyone has had launches on the brain – thanks largely to the Artemis II rocket and its ongoing lunar flyby mission.

However, there are a couple of health-related launches that are the focus of this week’s episode.

First up is the launch of HayloARC, a health-focused demand-side platform – better known as a DSP.

HayloARC is available for use by advertisers and medical marketing agencies seeking to better interface with HCPs and patients.

To accomplish this, HayloARC utilizes first-party HCP data derived from 30-plus medical publications owned by Haymarket Media, the parent company of MM+M.

For the feature conversation, editor-at-large Steve Madden sits down with Louis Naimoli, VP of programmatic business development and strategy at Haymarket, about what HayloARC is, how it’s differentiated from other DSPs and what it offers programmatic buyers in medical marketing.

Then, during our Trends segment, we’re talking about how the fight for GLP-1 supremacy between Novo Nordisk and Eli Lilly has shifted to the oral obesity pill battlefield.

We discuss Novo rolling out a multimonth subscription program for Wegovy and the FDA’s approval of Lilly’s daily oral weight loss drug Foundayo.

Music: “Deep Reflection” by DP and Triple Scoop Music.

Check us out at: mmm-online.com

Follow us:

YouTube: @MMM-online

TikTok: @MMMnews

Instagram: @MMMnewsonline

Twitter/X: @MMMnews

LinkedIn: MM+M

To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

Music: “Deep Reflection” by DP and Triple Scoop Music.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

At one point in time not too long ago, Weight Watchers was the legacy name in weight loss treatment.

Armed with an endorsement from board member Oprah Winfrey, everything was turning up Weight Watchers – until it wasn’t..

Usurped by powerful weight loss drugs manufactured by Eli Lilly and Novo Nordisk – along with ascendant telehealth firms like Ro, Hims & Hers, and Noom – Weight Watchers went into significant decline.

Ultimately, even Oprah left the company and donated her shares.

In May 2025, Weight Watchers filed for Chapter 11 bankruptcy in order to eliminate around $1.5 billion in debt. It emerged from bankruptcy in July and now has its sights set on repositioning itself as a key player in the GLP-1 age.

But what is Weight Watchers’ function in 2026?

This week, managing editor Jack O’Brien is joined by Scott Honken, PharmD, chief commercial officer at Weight Watchers, for an update on the company’s current standing in the GLP-1 landscape, where it’s been and where it’s going.

In lieu of our Trends segment, we have some audio takeouts from Jack’s time at SXSW, featuring leaders from Amgen, Marina Maher Communications and Compass Pathways.

Check us out at: mmm-online.com

Follow us:

YouTube: @MMM-online

TikTok: @MMMnews

Instagram: @MMMnewsonline

Twitter/X: @MMMnews

LinkedIn: MM+M

To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

Music: “Deep Reflection” by DP and Triple Scoop Music.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.